531541 — KOBO Biotech Cashflow Statement
0.000.00%
Last trade - 00:00- IN₹98.87m
- IN₹1.49bn
Annual cashflow statement for KOBO Biotech, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IAS | IAS | IAS | IAS | — |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -210 | -192 | -152 | -55.5 | -49.3 |
| Depreciation | |||||
| Non-Cash Items | 145 | 108 | 1.34 | 0 | 0 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 151 | 164 | 1,042 | 23.6 | 10.6 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 145 | 137 | 938 | 8.75 | 2.04 |
| Capital Expenditures | -0.027 | 0 | — | — | — |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | 251 | 0 | 0 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.027 | 0 | 251 | 0 | 0 |
| Financing Cash Flow Items | -145 | -108 | -1.34 | 0 | -9.46 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -145 | -122 | -1,203 | -8.74 | -1.5 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.017 | 14.3 | -14.3 | 0.006 | 0.536 |